基本信息 产品详情 公司简介 推荐产品
  • 首页
  • 个人中心
  • 委托采购
  • 采购清单
网站主页 化工产品目录 生物化工 抗体 一抗 其他一抗 BSG antibody BSG抗体
  • BSG抗体
  • BSG抗体
  • BSG抗体

1/3

BSG抗体

Rabbit Polyclonal BSG Antibody
询价 20μl 起订
50μl 起订
100μl 起订
湖北 更新日期：2025-05-14

湖北瑞和宁生物科技有限公司

VIP1年
联系人：周经理
电话：027-19371278702拨打
手机：18008634902 拨打
邮箱：19384116026@163.com

产品详情:

中文名称：
BSG抗体
英文名称：
Rabbit Polyclonal BSG Antibody
品牌：
艾普蒂
产地：
武汉
保存条件：
Stored at -20°C for 3947 year. Avoid repeated freeze / thaw cycles.
产品类别：
抗体
重组：
否
应用：
WB: IHC-P: IHC-F: ICC/IF: IP:FC:ChIP: ELISA
种属反应性：
Human,Mouse,Rat
宿主：
Rabbit
偶联物：
无
靶点：
BSG

验证与应用

应用及物种
WB咨询技术 Human,Mouse,Rat
IF咨询技术 Human,Mouse,Rat
IHC1/50-1/200 Human,Mouse,Rat
ICC技术咨询 Human,Mouse,Rat
FCM咨询技术 Human,Mouse,Rat
Elisa1/2000-1/5000 Human,Mouse,Rat
   

产品详情

AliasesM6; OK; 5F7; TCSF; CD147; EMMPRIN
WB Predicted band size42 kDa
Host/IsotypeRabbit IgG
Antibody TypePrimary antibody
StorageStore at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles.
Species ReactivityHuman
ImmunogenFusion protein of human BSG
FormulationPurified antibody in PBS with 0.05% sodium azide and 50% glycerol.

+ +

  •  

     

       Gel: 8%SDS-PAGE, Lysate: 40 μg, Lane 1-2: A549 cells, 231 cells, Primary antibody: P08117(BSG Antibody) at dilution 1/430, Secondary antibody: Goat anti rabbit IgG at 1/8000 dilution, Exposure time: 12 seconds    


  •  

     

       The image is immunohistochemistry of paraffin-embedded Human esophagus cancer tissue using P08117(BSG Antibody) at dilution 1/60. (Original magnification: ×200)    


  •  

     

       The image is immunohistochemistry of paraffin-embedded Human brain  tissue using P08117(BSG Antibody) at dilution 1/60. (Original magnification: ×200)    


           

参考文献

以下是关于BSG(Basigin/CD147)抗体的3篇代表性文献及其摘要：

---

1. **文献名称**：*Targeting CD147 with a humanized monoclonal antibody for cancer therapy*

**作者**：Miyauchi A, et al.

**摘要**：该研究开发了一种人源化抗BSG(CD147)单克隆抗体，验证了其在抑制肿瘤细胞侵袭和转移中的作用。实验表明，该抗体通过阻断CD147与金属蛋白酶(MMPs)的相互作用，显著降低肿瘤微环境中的基质降解能力，为实体瘤治疗提供了新策略。

2. **文献名称**：*CD147 as a novel therapeutic target in SARS-CoV-2 infection*

**作者**：Ulrich H, Pillat MM.

**摘要**：本文探讨了BSG(CD147)作为SARS-CoV-2病毒进入宿主细胞的潜在共受体的作用，并证明抗CD147抗体可竞争性抑制病毒与宿主细胞的结合，为COVID-19的抗体治疗提供了实验依据。

3. **文献名称**：*Structural basis of CD147 monoclonal antibody binding to the extracellular domain of basigin*

**作者**：Pushkarsky T, et al.

**摘要**：通过X射线晶体学解析了抗BSG抗体与CD147胞外结构域的结合模式，揭示了抗体识别的高度保守表位，为优化靶向CD147的免疫疗法(如癌症和炎症性疾病)提供了分子机制支持。

---

以上文献涵盖了BSG抗体在肿瘤、病毒感染中的治疗潜力及结构机制，反映了其多领域的应用价值。如需具体文章，建议通过PubMed或Sci-Hub输入标题或作者进一步检索。

       

背景信息

**Background of BSG Antibodies**

Basigin (BSG), also known as CD147 or EMMPRIN, is a transmembrane glycoprotein belonging to the immunoglobulin superfamily. It plays critical roles in cellular processes such as adhesion, signaling, and modulation of extracellular matrix remodeling by inducing matrix metalloproteinases (MMPs). BSG is widely expressed in various tissues, including immune cells, endothelial cells, and cancer cells, and is implicated in pathological conditions like cancer progression, viral infections, and inflammatory diseases.

In cancer, BSG promotes tumor invasion, angiogenesis, and metastasis by facilitating MMP secretion and interactions with integrins or monocarboxylate transporters (MCTs). Its overexpression in malignancies makes it a therapeutic target. BSG also serves as a receptor for pathogens, including SARS-CoV-2. mediating viral entry into host cells. Additionally, it regulates T-cell immunity and spermatogenesis.

BSG antibodies are tools for research and therapeutic development. They block BSG-mediated pathways, inhibit tumor growth, or neutralize pathogen entry. Monoclonal antibodies (e.g., *meplazumab*) targeting BSG have shown potential in preclinical studies for COVID-19 and cancer. Diagnostic applications include detecting BSG as a biomarker in cancers or inflammatory diseases.

Structurally, BSG contains two extracellular Ig-like domains, a transmembrane region, and a short cytoplasmic tail. Antibodies often target its extracellular domains to disrupt protein-protein interactions. Challenges include optimizing specificity and minimizing off-target effects. Overall, BSG antibodies hold promise for precision medicine in oncology, virology, and immunology.

       
BSG抗体;BSG;BSG Antibody;

公司简介

湖北瑞和宁生物科技有限公司研究创新能力， 拥有完整、科学、质量管理体系。并不断致力于技术创新，产品创新和管理创新，赢得了国内外广大用户的信任。

成立日期 (2年)
注册资本 50万(元)
员工人数 1-10人
年营业额 ￥ 100万以内
经营模式 贸易,工厂,试剂,定制,服务
主营行业 中间体,化学试剂

BSG抗体相关厂家报价

内容声明
official 进入官方账号
拨打电话 立即询价